Key differential aspects of the group of glucagon-like peptide-1 receptor agonist drugs There are several arGLP-1 s approved or under study for the use in DM2: exenatide (exenatide and exenatide LAR or weekly), liraglutide, lixisenatide, dulaglutide, semaglutide, albiglutide (withdrawn from the market), and efpeglenatide (in clinical development)
What youll learn Youll get a clear breakdown of how GLP-1 medications work, which ones are available, and practical insight into what to expect in terms of benefits and side effects
Meet our experts: Kerri Louati , MS, RD, LDN, CDE, director of women's health clinical operations at LifeMD
Buyers are placing more weight on formulation clarity and ease of use than on trend-led marketing language